TABLE 5.
Significantly enriched GO terms and KEGG pathways of low risk group.
| GO | ID | Description | NSE | p |
|---|---|---|---|---|
| BP | GO:0002704 | Regulation of leukocyte mediated immunity | 2.14 | 0.015 |
| BP | GO:0032480 | Regulation of type I interferon production | 2.12 | 0.014 |
| BP | GO:0002707 | Regulation of lymphocyte mediated immunity | 2.10 | 0.014 |
| BP | GO:0002710 | Regulation of T cell mediated immunity | 2.08 | 0.016 |
| BP | GO:0031312 | Extrinsic component of organelle membrane | 2.06 | 0.022 |
| KEGG | hsa04623 | Cytosolic DNA sensing pathway | 1.93 | 0.002 |
| KEGG | hsa00190 | Oxidative phosphorylation | 1.89 | 0.006 |
| KEGG | hsa05322 | Systemic lupus erythematosus | 1.87 | 0.002 |
| KEGG | hsa05320 | Autoimmune thyroid disease | 1.87 | 0.002 |
| KEGG | hsa04612 | Antigen processing and presentation | 1.80 | 0.012 |
BP, biological process; CC, cellular component; GO, Gene Ontology; MF, molecular function.